Mr. Chair, I'm saying that with the recent news from Mitsubishi and Medicago, coupled with the demand and our constant review of contracts, there are active negotiations going on right now looking at the 20 million doses and what can be done to adjust it.
On February 6th, 2023. See this statement in context.